Royalty Pharma plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 02/13/2026 | 55.27 M | $2.14 B | 25.16% | 12.86% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 31.10 M | $1.20 B | 14.30% | 7.24% |
| FMR LLC | 02/17/2026 | 26.27 M | $1.02 B | -6.13% | 6.11% |
| BLACKROCK, INC. | 02/12/2026 | 26.19 M | $1.01 B | -0.05% | 6.09% |
| BAILLIE GIFFORD & CO | 01/23/2026 | 17.01 M | $657.22 M | -2.09% | 3.94% |
| SWEDBANK AB | 02/09/2026 | 11.94 M | $461.44 M | -2.12% | 2.78% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 11.74 M | $453.66 M | -1.88% | 2.74% |
| STATE STREET CORP | 02/13/2026 | 10.65 M | $411.50 M | 3.67% | 2.48% |
| VANGUARD GROUP INC | 01/29/2026 | 9.93 M | $383.87 M | -9.16% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 7.72 M | $297.47 M | 1.34% | 1.80% |
| CALEDONIA (PRIVATE) INVESTMENTS PTY LTD | 02/17/2026 | 7.38 M | $285.05 M | -2.26% | 1.72% |
| CITADEL ADVISORS LLC | 02/17/2026 | 5.27 M | $203.78 M | 1,236.26% | 1.23% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 5.11 M | $197.33 M | 9.65% | 1.19% |
| JANE STREET GROUP, LLC | 02/12/2026 | 4.95 M | $191.17 M | 56.98% | 1.15% |
| NORTHERN TRUST CORP | 02/17/2026 | 4.00 M | $154.69 M | -1.76% | 0.93% |
| NORGES BANK | 02/10/2026 | 3.41 M | $131.92 M | 100.00% | 0.79% |
| PATIENT CAPITAL MANAGEMENT, LLC | 02/13/2026 | 3.33 M | $128.81 M | 6.92% | 0.78% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 3.31 M | $128.02 M | 0.95% | 0.77% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 3.12 M | $120.51 M | -0.35% | 0.73% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 3.09 M | $119.32 M | 9.41% | 0.72% |
| NEW SOUTH CAPITAL MANAGEMENT INC | 02/12/2026 | 2.93 M | $113.17 M | 0.36% | 0.68% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 2.91 M | $112.57 M | -3.71% | 0.68% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.71 M | $104.67 M | 2.35% | 0.63% |
| AMUNDI | 02/17/2026 | 2.68 M | $103.53 M | 29.44% | 0.63% |
| REGAL PARTNERS LTD | 02/18/2026 | 2.64 M | $102.04 M | 84.01% | 0.61% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.56 M | $99.06 M | 30.73% | 0.60% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 2.47 M | $95.41 M | -0.51% | 0.57% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 2.31 M | $89.35 M | 10.08% | 0.54% |
| DORSEY ASSET MANAGEMENT, LLC | 02/17/2026 | 2.26 M | $87.31 M | -3.87% | 0.53% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 2.19 M | $84.43 M | 12.84% | 0.51% |
| UBS GROUP AG | 01/29/2026 | 2.01 M | $77.51 M | 30.11% | 0.47% |
| CLARK CAPITAL MANAGEMENT GROUP, INC. | 02/17/2026 | 1.75 M | $67.77 M | 0.11% | 0.41% |
| MITSUBISHI UFJ TRUST & BANKING CORP | 01/30/2026 | 1.76 M | $68.17 M | 16.17% | 0.41% |
| HOMESTEAD ADVISERS CORP | 02/10/2026 | 1.67 M | $64.59 M | -12.14% | 0.39% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.58 M | $61.02 M | 4.15% | 0.37% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 1.56 M | $60.13 M | 126.93% | 0.36% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.55 M | $59.93 M | -5.76% | 0.36% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.52 M | $58.68 M | -13.70% | 0.35% |
| INVESCO LTD. | 02/19/2026 | 1.50 M | $58.04 M | -5.50% | 0.35% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 1.47 M | $56.76 M | 1.16% | 0.34% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 1.40 M | $54.11 M | -0.49% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 1.34 M | $51.77 M | 5.35% | 0.31% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 1.30 M | $50.18 M | 41.50% | 0.30% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 1.27 M | $49.00 M | 15.11% | 0.29% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.23 M | $47.66 M | 19.66% | 0.29% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 1.23 M | $45.40 M | 20.88% | 0.29% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.21 M | $46.60 M | 27.07% | 0.28% |
| SWISS NATIONAL BANK | 02/12/2026 | 1.13 M | $43.49 M | 2.95% | 0.26% |
| 02/02/2026 | 1.12 M | $43.59 M | 100.00% | 0.26% | |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 1.07 M | $41.16 M | 31.21% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Royalty Pharma plc institutional Ownership - FAQ's
During the previous two years, 666 institutional investors and hedge funds held shares of Royalty Pharma plc. The most heavily invested institutionals were:
Swedbank AB: 11.59 M
ROYAL LONDON ASSET MANAGEMENT LTD: 3.81 M
UBS Group AG: 1.81 M
HSBC HOLDINGS PLC: 1.54 M
Bank of New York Mellon Corp: 1.3 M
Sumitomo Mitsui Trust Holdings, Inc.: 1.27 M
83.03% of Royalty Pharma plc stock is owned by institutional investors.
Institutional investors have bought a total of 400.49 M shares in the last 24 months. This purchase volume represents approximately $18.36 B in transactions.